0001209191-18-008213.txt : 20180207
0001209191-18-008213.hdr.sgml : 20180207
20180207180635
ACCESSION NUMBER: 0001209191-18-008213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180205
FILED AS OF DATE: 20180207
DATE AS OF CHANGE: 20180207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman William
CENTRAL INDEX KEY: 0001730229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 18582211
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-05
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001730229
Grossman William
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Sr. VP, Chief Medical Officer
Common Stock
2018-02-05
4
A
0
30000
0.00
A
30000
D
Employee Stock Option (right to buy)
5.61
2018-02-05
4
A
0
175000
0.00
A
2028-02-04
Common Stock
175000
175000
D
Represents grant of restricted stock units payable solely in common stock that vest in four equal annual installments on each anniversary of February 5, 2018.
25% of the shares subject to the stock option vest and become exercisable on February 5, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
/s/ Alan Musso, Attorney-in-Fact
2018-02-07